Chemokines in Cancer Development and Progression and Their Potential as Targeting Molecules for Cancer Treatment

Chemokines were initially identified as bioactive substances, which control the trafficking of inflammatory cells including granulocytes and monocytes/macrophages. Moreover, chemokines have profound impacts on other types of cells associated with inflammatory responses, such as endothelial cells and...

Full description

Saved in:
Bibliographic Details
Main Authors: Naofumi Mukaida, So-ichiro Sasaki, Tomohisa Baba
Format: Article
Language:English
Published: Wiley 2014-01-01
Series:Mediators of Inflammation
Online Access:http://dx.doi.org/10.1155/2014/170381
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832559050982686720
author Naofumi Mukaida
So-ichiro Sasaki
Tomohisa Baba
author_facet Naofumi Mukaida
So-ichiro Sasaki
Tomohisa Baba
author_sort Naofumi Mukaida
collection DOAJ
description Chemokines were initially identified as bioactive substances, which control the trafficking of inflammatory cells including granulocytes and monocytes/macrophages. Moreover, chemokines have profound impacts on other types of cells associated with inflammatory responses, such as endothelial cells and fibroblasts. These observations would implicate chemokines as master regulators in various inflammatory responses. Subsequent studies have further revealed that chemokines can regulate the movement of a wide variety of immune cells including lymphocytes, natural killer cells, and dendritic cells in both physiological and pathological conditions. These features endow chemokines with crucial roles in immune responses. Furthermore, increasing evidence points to the vital effects of several chemokines on the proliferative and invasive properties of cancer cells. It is widely acknowledged that cancer develops and progresses to invade and metastasize in continuous interaction with noncancerous cells present in cancer tissues, such as macrophages, lymphocytes, fibroblasts, and endothelial cells. The capacity of chemokines to regulate both cancerous and noncancerous cells highlights their crucial roles in cancer development and progression. Here, we will discuss the roles of chemokines in carcinogenesis and the possibility of chemokine targeting therapy for the treatment of cancer.
format Article
id doaj-art-08b5cb63514a43688d1aac70319c9040
institution Kabale University
issn 0962-9351
1466-1861
language English
publishDate 2014-01-01
publisher Wiley
record_format Article
series Mediators of Inflammation
spelling doaj-art-08b5cb63514a43688d1aac70319c90402025-02-03T01:30:52ZengWileyMediators of Inflammation0962-93511466-18612014-01-01201410.1155/2014/170381170381Chemokines in Cancer Development and Progression and Their Potential as Targeting Molecules for Cancer TreatmentNaofumi Mukaida0So-ichiro Sasaki1Tomohisa Baba2Division of Molecular Bioregulation, Cancer Research Institute, Kanazawa University, Kakuma-machi, Kanazawa 920-1192, JapanDivision of Molecular Bioregulation, Cancer Research Institute, Kanazawa University, Kakuma-machi, Kanazawa 920-1192, JapanDivision of Molecular Bioregulation, Cancer Research Institute, Kanazawa University, Kakuma-machi, Kanazawa 920-1192, JapanChemokines were initially identified as bioactive substances, which control the trafficking of inflammatory cells including granulocytes and monocytes/macrophages. Moreover, chemokines have profound impacts on other types of cells associated with inflammatory responses, such as endothelial cells and fibroblasts. These observations would implicate chemokines as master regulators in various inflammatory responses. Subsequent studies have further revealed that chemokines can regulate the movement of a wide variety of immune cells including lymphocytes, natural killer cells, and dendritic cells in both physiological and pathological conditions. These features endow chemokines with crucial roles in immune responses. Furthermore, increasing evidence points to the vital effects of several chemokines on the proliferative and invasive properties of cancer cells. It is widely acknowledged that cancer develops and progresses to invade and metastasize in continuous interaction with noncancerous cells present in cancer tissues, such as macrophages, lymphocytes, fibroblasts, and endothelial cells. The capacity of chemokines to regulate both cancerous and noncancerous cells highlights their crucial roles in cancer development and progression. Here, we will discuss the roles of chemokines in carcinogenesis and the possibility of chemokine targeting therapy for the treatment of cancer.http://dx.doi.org/10.1155/2014/170381
spellingShingle Naofumi Mukaida
So-ichiro Sasaki
Tomohisa Baba
Chemokines in Cancer Development and Progression and Their Potential as Targeting Molecules for Cancer Treatment
Mediators of Inflammation
title Chemokines in Cancer Development and Progression and Their Potential as Targeting Molecules for Cancer Treatment
title_full Chemokines in Cancer Development and Progression and Their Potential as Targeting Molecules for Cancer Treatment
title_fullStr Chemokines in Cancer Development and Progression and Their Potential as Targeting Molecules for Cancer Treatment
title_full_unstemmed Chemokines in Cancer Development and Progression and Their Potential as Targeting Molecules for Cancer Treatment
title_short Chemokines in Cancer Development and Progression and Their Potential as Targeting Molecules for Cancer Treatment
title_sort chemokines in cancer development and progression and their potential as targeting molecules for cancer treatment
url http://dx.doi.org/10.1155/2014/170381
work_keys_str_mv AT naofumimukaida chemokinesincancerdevelopmentandprogressionandtheirpotentialastargetingmoleculesforcancertreatment
AT soichirosasaki chemokinesincancerdevelopmentandprogressionandtheirpotentialastargetingmoleculesforcancertreatment
AT tomohisababa chemokinesincancerdevelopmentandprogressionandtheirpotentialastargetingmoleculesforcancertreatment